Aptimmune Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
Aptimmune General Information
Description
Developer of novel swine mucosal vaccines designed to offer effective protection from viral diseases. The company's vaccines address two major viral respiratory pathogens, porcine reproductive and respiratory virus, and influenza A virus in swine, enabling animal breeders to ensure a lasting immune response and disease protection.
Contact Information
Website
www.aptimmune.comCorporate Office
- 1234 Hanley Industrial Court
- Saint Louis, MO 63134
- United States
Corporate Office
- 1234 Hanley Industrial Court
- Saint Louis, MO 63134
- United States
Aptimmune Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Later Stage VC (Series B) | 22-Jan-2018 | Completed | Generating Revenue | |||
| 8. Grant | 31-Dec-2017 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 17-Nov-2016 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 24-Mar-2016 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series AA) | Completed | Startup | ||||
| 2. Grant | 31-Dec-2015 | $100K | Completed | Startup | ||
| 1. Accelerator/Incubator | Completed | Startup |
Aptimmune Comparisons
Industry
Financing
Details
Aptimmune Competitors (1)
One of Aptimmune’s competitors is Diamond V, a Corporate Backed or Acquired company based in Cedar Rapids, IA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Diamond V | Corporate Backed or Acquired | Cedar Rapids, IA |
Aptimmune Patents
Aptimmune Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3146409-A1 | Methods for growing african swine fever virus in fetal porcine lung alveolar macrophage cells | Pending | 11-Jul-2019 | ||
| EP-3787679-A1 | Methods for growing african swine fever virus in fetal porcine lung alveolar macrophage cells | Pending | 11-Jul-2019 | ||
| EP-3787679-A4 | Methods for growing african swine fever virus in fetal porcine lung alveolar macrophage cells | Pending | 11-Jul-2019 | ||
| US-12606803-B2 | Methods for growing african swine fever virus in fetal porcine lung alveolar macrophage cells | Active | 11-Jul-2019 | ||
| US-20220259569-A1 | Methods for growing african swine fever virus in fetal porcine lung alveolar macrophage cells | Active | 11-Jul-2019 | A61K39/12 |
Aptimmune Signals
Aptimmune FAQs
-
When was Aptimmune founded?
Aptimmune was founded in 2010.
-
Where is Aptimmune headquartered?
Aptimmune is headquartered in Saint Louis, MO.
-
What is the size of Aptimmune?
Aptimmune has 6 total employees.
-
What industry is Aptimmune in?
Aptimmune’s primary industry is Other Commercial Products.
-
Is Aptimmune a private or public company?
Aptimmune is a Private company.
-
What is Aptimmune’s current revenue?
The current revenue for Aptimmune is .
-
How much funding has Aptimmune raised over time?
Aptimmune has raised $8.85M.
-
Who are Aptimmune’s competitors?
Diamond V is a competitor of Aptimmune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process